Enzymit Inc. closes $5M seed round for biochemicals, enzymatic tech

In Israel, Enzymit Inc., a syn-bio production platform company, closed a $5 million seed round to accelerate the development of its computational design platform based on enzymatic manufacturing and expand its product pipeline with the new investment.

The company uses its computational design platform to engineer ‘new-to-nature’ enzymes for bio-production. These designer enzymes can replace nearly every inefficient, unsustainable and polluting chemical reaction used in modern production methods. Moreover, enzymes are capable of manufacturing complex molecules and materials that are impossible to manufacture any other way.

Enzymit is developing computational design tools that generate ‘new-to-nature’ enzymes that can not only catalyze new reactions but also outperform existing enzymes. These enzymes are then used in a ‘cell-free’ process, eliminating all of the problems associated with cellular manufacturing and cutting production costs and development times.

Enzymit is developing a novel enzymatic process that can convert carbon from the air to novel bio-polymers cheaper than ever before and plans to challenge some of the largest players with its innovative platform and products. With this new investment, the company is well-positioned to take on the challenge and significantly impact this important market.